CompletedPhase 4NCT03528967
Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women
Studying Placental insufficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Les Laboratoires des Médicaments Stériles
- Principal Investigator
- Dalenda Chelly, OB/GYNWassila Bourguiba Hospital Tunis
- Intervention
- Enoxaparin 40 mg / 0.4 mL Prefilled Syringe(drug)
- Enrollment
- 89 target
- Eligibility
- 18-45 years · FEMALE
- Timeline
- 2013 – 2018
Study locations (1)
- Maternity Center of Wassila Bourguiba Hospital - Department A, Tunis, Tunisia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03528967 on ClinicalTrials.govOther trials for Placental insufficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07098975Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- RECRUITINGNCT07470320Placental Biology in Health and DiseaseUniversity of Oxford
- RECRUITINGPHASE3NCT06723392Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE CountriesNICHD Global Network for Women's and Children's Health
- RECRUITINGNCT07144839Placental Risk Assessment to CusTomize Individualized Pregnancy Care and EvaluationOregon Health and Science University
- RECRUITINGNCT06861309Placental Imaging TechniquesCarilion Clinic
- RECRUITINGPHASE3NCT06497959Study of Placental Vascularization Using Contrast UltrasoundCentral Hospital, Nancy, France
- RECRUITINGNCT06343051USCOM in Newly Diagnosed FGR CasesIcahn School of Medicine at Mount Sinai
- RECRUITINGNCT06893926Cord Blood S100B Protein Concentration in Neonates With Fetal Growth RestrictionInstitute of Mother and Child, Warsaw, Poland